ClinicalTrials.gg
CompletedNCT07923942Updated Nov 9, 2026

Cerebral Monitoring and Postoperative Delirium in Pediatric Cardiac Surgery

An observational study in Congenital Heart Disease, Pediatric Open Heart Surgery and Delirium - Postoperative, sponsored by Universitas Indonesia. Completed at 1 site in Indonesia. Open to participants aged 1 Year to 18 Years. Per ClinicalTrials.gov, last updated 2026-11-09.

Sponsored by Universitas Indonesia · Observational

Updated Nov 9, 2026Newly registeredGo to Updates ↓
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
42
Ages
1 Year to 18 Years
Sex
All
01

Study summary

The goal of this observational study is to examine the relationship between intraoperative cerebral blood flow and perfusion with postoperative delirium in pediatric patients undergoing open-heart surgery.

The main questions it aims to answer are:

Is there a correlation between changes in cerebral blood flow measured by Transcranial Color-Coded Duplex (TCCD) and changes in cerebral perfusion measured by Near-Infrared Spectroscopy (NIRS) during open-heart surgery in pediatric patients? Is there a correlation between reduced cerebral blood flow measured by TCCD and the occurrence of postoperative delirium in pediatric open-heart surgery patients? Is there a correlation between changes in cerebral perfusion measured by NIRS and the occurrence of postoperative delirium in pediatric open-heart surgery patients?

Pediatric patients undergoing open-heart surgery with cardiopulmonary bypass at Cipto Mangunkusumo Hospital (RSCM) will undergo intraoperative cerebral monitoring using TCCD and NIRS. Following surgery, participants will be assessed for delirium during their postoperative ICU stay using the Indonesian version of the Cornell Assessment of Pediatric Delirium (i-CAPD), a validated pediatric delirium screening tool adapted for Indonesian clinical settings.

Read the detailed description

Postoperative delirium is a serious neurological complication following pediatric open-heart surgery, associated with prolonged ICU stay, increased morbidity, and adverse neurodevelopmental outcomes. Despite its clinical significance, the underlying cerebrovascular mechanisms contributing to delirium in this population remain incompletely understood.

Cardiopulmonary bypass (CPB) during open-heart surgery exposes the pediatric brain to significant hemodynamic alterations, including non-pulsatile flow, hypothermia, hemodilution, and microemboli. These factors may impair cerebral autoregulation and reduce cerebral oxygen delivery, potentially contributing to neurological injury and subsequent delirium.

This study employs two complementary neuromonitoring modalities:

Transcranial Color-Coded Duplex (TCCD) will be used to measure intraoperative cerebral blood flow velocity in the middle cerebral artery (MCA), including mean flow velocity (MFV). Changes in these parameters reflect alterations in flow dynamics during CPB.

Near-Infrared Spectroscopy (NIRS) will be used to continuously monitor regional cerebral oxygen saturation (rSO₂) throughout the intraoperative period. Significant desaturation events, defined as a decrease in rSO₂ of more than 20% from baseline or an absolute value below 40%, will be recorded.

Delirium assessment will be performed postoperatively in the pediatric cardiac ICU using the i-CAPD (Indonesian version of the Cornell Assessment of Pediatric Delirium) at regular intervals at 24, 48 and 72 hours after RAAS score ≥-2. The i-CAPD has been validated for use in Indonesian pediatric populations and is applicable across all age groups and developmental stages.

Correlation analyses will be performed between intraoperative TCCD and NIRS parameters and the occurrence and severity of postoperative delirium, adjusting for relevant perioperative covariates including age, diagnosis, CPB duration, aortic cross-clamp time, and hemodynamic parameters.

02

Conditions studied

  • Congenital Heart Disease
  • Pediatric Open Heart Surgery
  • Delirium - Postoperative
  • Transcranial Doppler Ultrasound
  • Near Infrared Spectroscopy

Keywords

  • congenital heart disease
  • pediatric open heart surgery
  • postoperative delirium
  • cerebral monitoring
  • transcranial color coded doppler
  • near infrared spectroscopy
03

In context

Heart Defects, Congenital

991 studies on the registry are indexed under Heart Defects, Congenital; 251 are open to participants now.

This study's enrollment of 42 is below the median of 119 across 440 observational studies indexed under Heart Defects, Congenital.

Browse Heart Defects, Congenital studies →

Lead sponsor

Universitas Indonesia is the lead sponsor of 35 studies on the registry; 13 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
1 Year to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Pediatric patients with congenital heart disease undergoing open-heart surgery with cardiopulmonary bypass.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Pediatric patients with congenital heart disease scheduled for elective open-heart surgery with cardiopulmonary bypass
  • Age 1 to 18 years
  • Written obtained from parent or legal guardian

Exclusion criteria

Exclusion Criteria:

  • Pre-existing severe neurological disorder
  • Absence of adequate temporal acoustic window for Transcranial Color-Coded Duplex (TCCD) examination
  • Active infection or severe comorbidity that may confound the study results
  • Clinical deterioration prior to the scheduled elective surgery
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
42 participants (actual)
Patient registry
No

Groups and cohorts

  • Patients aged 1-18 years with congenital heart disease undergoing elective open-heart surgery

    Pediatric patients aged 1-18 years with congenital heart disease undergoing elective open-heart surgery with cardiopulmonary bypass at Cipto Mangunkusumo Hospital (RSCM), Jakarta, Indonesia. All participants will undergo intraoperative cerebral monitoring using TCCD and NIRS, and postoperative delirium assessment using the i-CAPD.

06

What researchers measure

Primary outcomes

  1. Postoperative delirium

    Postoperative delirium will be assessed using the Indonesian version of the Cornell Assessment of Pediatric Delirium (i-CAPD). The i-CAPD is an 8-item observational tool completed by bedside nurses, evaluating eye contact, purposeful actions, awareness of surroundings, restlessness, inconsolability, and movement. A score of ≥9 indicates delirium. Assessment will be performed every 12 hours during the postoperative ICU stay, beginning upon admission to the pediatric cardiac ICU following surgery.

    Time frame: 24, 48, 72 hours after RAAS score≥-2

07

Study locations

1 site
  • Cipto Mangunkusumo National Hospital (RS Cipto Mangunkusumo)
    Jakarta, Dki Jakarta 10430, Indonesia
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Apr 2026 to primary completion in Aug 2026, 4 months.

Of 178 non-industry observational studies under Heart Defects, Congenital, half reached primary completion within 42 months of starting (the median), counting those still running; a quarter within 17 and three quarters within 83. This study's 4 months is below that.

Counting every sponsor, half of 185 studies reached it within 44 months; a quarter within 17 and three quarters within 83.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 3, 2026
First posted
Nov 9, 2026
StartActual
Apr 1, 2026
Primary completionActual
Aug 1, 2026
CompletionActual
Sep 1, 2026
Last update
Nov 9, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 9, 2026
Show all 1 update
  1. Nov 9, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07923942
Lead sponsor
Universitas Indonesia
Responsible party
Ratna Farida Soenarto (Dr. dr. Ratna Farida Soenarto, SpAn-TI, Subsp. An.Kv (K), Universitas Indonesia) — Principal investigator
First posted
Nov 9, 2026
Start date
Apr 1, 2026
Primary completion
Aug 1, 2026
Completion
Sep 1, 2026
Last update
Nov 9, 2026

Study contacts

Ratna F Soenarto, Dr., dr., SpAn-TI, Subsp.AKV
study chair · Universitas Indonesia
Jane E Sentosa, dr., SpAn_TI
principal investigator · Universitas Indonesia
Aldy Heriwardito, dr., SpAn-TI, Subsp.AKV
study chair · Universitas Indonesia
Riyadh Firdaus, Dr., dr., SpAn-TI, Subsp.NA(K)
study chair · Universitas Indonesia

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion